The MDS-AS 2nd Virtual Interactive Course: Principles of Movement Disorders is a 10-week course comprised of 5 module topics, each topic structured over a two-week period with all course content and interactions occurring entirely via the LMS course platform. This innovative course format features topics led by international movement disorder experts on the basics of movement disorders, including Parkinson's disease, atypical and acquired parkinsonism, tremor, dystonia, chorea, drug induced movement disorders, myoclonus, tics and pediatric movement disorders.
- Biomarkers & Diagnostic Tools
- Hyperkinetic Movement Disorders
- Other Movement Disorders
- Parkinson Disease/Hypokinetic Movement Disorders
Ali S. Shalash, MD, PhD - Ain Shams University, Cairo, Egypt
The primary purpose of this course is to provide an overview of various Movement Disorders. This 10 week course is different than previous online courses and consists of 5 modular topics, each topic structured over a two-week period as follows:
- Movement Disorders (Clinical Approaches): May 5, 2022 - May 18, 2022
- Parkinson's Disease and Parkinsonism: May 19, 2022 - June 1, 2022
- Management of Parkinson's Disease: June 2, 2022 - June 15, 2022
- Hyperkinetic Movement Disorders (Dystonia; Chorea/Drug Induced): June 16, 2022 - June 29, 2022
- Hyperkinetic Movement Disorders Continued (Myoclonus, Tremor, Tics and Pediatric Movement Disorders): June 30, 2022 - July 13, 2022
Please note registration is for the entire course duration (May 5 - July 13). Please also note registration capacity is limited to keep group size small.
MDS Members: Free
Non-Members: $50 USD
*Non-members from the MDS-Africa region can apply for a FREE No-Fee membership with MDS and register for this course at no cost. Must apply for membership no later than 2 weeks in advance of the session.
To view additional details please click 'PROCEED TO COURSE'
May 5, 2022 - July 13, 2022
To view a detailed schedule, please click HERE.
This 10-week course consists of 5 module topics, each topic structured over a two week period with all course content and interactions occurring entirely via the LMS course platform through lectures, participants' completion of independent work and group activities moderated by faculty, and continuous dialoguing between expert faculty, participants, and peers via the course discussion board as follows:
Week 1: Module Release
Day 1: Lectures made available for on-demand viewing; supplemental resources posted for additional education
Day 1 - 7: Participants will watch lectures on demand, complete supplemental resources for additional education and submit questions/comments/case presentations to faculty via the Ask The Expert Feature on the LMS course platform.
Week 2: Interactive Components
Day 8 - 14: Throughout this week participants will complete independent work and group activities moderated by faculty, prepare interesting cases for discussion and submit Ask the Expert questions/comments to faculty for individualized feedback and expert commentary. Replies from faculty will be posted on the course discussion board for all participants to view and further dialogue.
Upon completion of this activity learners will be able to:
- Summarize the approach to correct history of patients with movement disorders
- Examine a patient with a movement disorder
- Identify the causes and correct management of movement disorders
- Compose a formal case presentation
- Join collaborate discussions and consultations amongst peers
This activity is intended for general neurologists, movement disorders fellows, clinical scientists, senior and young neurology residents interested in specializing in movement disorders.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The International Parkinson and Movement Disorder Society designates this activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.
Method of Participation
Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.
All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.
|Ali Shalash||Planner, Speaker||Nothing To Disclose|
|Jonathan Carr||Speaker||Nothing To Disclose|
|Njideka Okubadejo||Speaker||Nothing To Disclose|
|Maria Stamelou||Speaker||Nothing To Disclose|
|Ronald Postuma||Speaker||Consultant: Takeda, Roche/Prothena, Teva Neurosciences, Novartis, Biogen, Boehringer Ingelheim, Theranexus, Merck, AbbVie, Jannsen, Curasen, Inception Sciences|
|Angelo Antonini||Speaker||Nothing To Disclose|
|Susanne Schneider||Speaker||Nothing To Disclose|
|Francesca Morgante||Speaker||Nothing To Disclose|
|Roberto Erro||Speaker||Nothing To Disclose|
Hardware and Software Requirements
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.
MDS Secretariat Liaison